share_log

Alliance Global Partners Maintains Buy on Profound Medical, Raises Price Target to $15.75

Alliance Global Partners Maintains Buy on Profound Medical, Raises Price Target to $15.75

聯盟全球合作伙伴維持對Profound Medical的買入,將目標股價上調至15.75美元
Benzinga ·  2023/05/11 06:48

Alliance Global Partners analyst Ben Haynor maintains Profound Medical (NASDAQ:PROF) with a Buy and raises the price target from $13.15 to $15.75.

Alliance Global Partners分析師本·海納維持深奧醫療(納斯達克:PROF)的買入,並將目標價從13.15美元上調至15.75美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論